Last reviewed · How we verify
BioCis Pharma Ltd — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
3 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Dermatology · 2
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
- Al-Azhar University · 1 shared drug class
- Aldeyra Therapeutics, Inc. · 1 shared drug class
- All India Institute of Medical Sciences, Bhubaneswar · 1 shared drug class
- Apotex Inc. · 1 shared drug class
- Astellas Pharma Inc · 1 shared drug class
- Astion Pharma A/S · 1 shared drug class
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for BioCis Pharma Ltd:
- BioCis Pharma Ltd pipeline updates — RSS
- BioCis Pharma Ltd pipeline updates — Atom
- BioCis Pharma Ltd pipeline updates — JSON
Cite this brief
Drug Landscape (2026). BioCis Pharma Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biocis-pharma-ltd. Accessed 2026-06-10.